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Open access under CC BY license.The report of methicillin-resistant Staphylococcus aureus
(MRSA) encoding a divergent mecA gene in 2011 was
highly significant. This homologue, designated mecC,
poses diagnostic problems with the potential to be mis-
diagnosed as methicillin-sensitive S. aureus, with impor-
tant potential consequences for individual patients and
for the surveillance of MRSA. mecC MRSA have now been
reported from 13 European countries and have been
isolated from 14 different host species, with evidence
of a recent increase in Denmark. The emergence of mecC
MRSA is a topic of interest to human and veterinary
microbiology, and we consider it timely to review here
its discovery and subsequent investigation.
Staphylococcus aureus and MRSA in humans and
animals
S. aureus is a prominent human pathogen that can cause a
diverse range of diseases ranging from relatively minor
skin infections to serious and life-threatening infections
such as endocarditis, pneumonia, and sepsis. Its impact is
enhanced by the development of antibiotic resistance, most
notably methicillin-resistant S. aureus (MRSA) that is
resistant to virtually all b-lactam antibiotics. Although
originally regarded as a nosocomial pathogen (hospital-
associated MRSA or HA-MRSA), MRSA infections among
previously healthy individuals in the community, without
links to healthcare settings, emerged in the 1990s and are
referred to as community-associated MRSA (CA-MRSA).
For the most part HA-MRSA and CA-MRSA involve differ-
ent lineages, but these distinctions are not absolute, and
transfer of strains between these settings is increasingly
recognised. In addition to its importance as a human
pathogen, S. aureus [1], including MRSA [2,3], can colonise
and infect a wide range of host species including livestock,
wildlife, and companion animals, with bovine mastitis
among dairy cattle, lameness in poultry, and severe and
lethal infections in farmed rabbits being particularly0966-842X
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is not only important from an animal welfare and economic
perspective but can act as a reservoir for zoonotic infection
of humans. In particular, multilocus sequence type clonal
complex (CC)398 is abundant among pigs and other live-
stock in mainland Europe, and infection of humans in close
contact with these animals has led to the recognition of a
third epidemiological form of MRSA, livestock-associated
MRSA (LA-MRSA) [4].
Mechanism of methicillin-resistance in MRSA and its
diagnostic detection
Although methicillin is no longer produced, the name
MRSA has persisted and can be regarded as referring to
resistance to virtually all b-lactam antibiotics. Suscepti-
bility testing now typically uses oxacillin and/or cefoxitin.
b-Lactams bind to the penicillin-binding proteins (PBP)
essential for cell wall biosynthesis and inhibit peptidogly-
can crosslink formation, leading to bacterial cell lysis.
Resistance to b-lactams in MRSA is conferred by the
acquisition of a mobile genetic element, the staphylococcal
cassette chromosome (SCCmec) carrying the mecA gene
which encodes an altered PBP – PBP2a/PBP20 – which has
reduced affinity for b-lactam antibiotics. As a result, cell
wall biosynthesis in MRSA strains continues even in the
presence of otherwise inhibitory levels of b-lactam anti-
biotics. The detection and diagnosis of MRSA in the clinical
microbiology setting is very important both for informing
the appropriate treatment of individual patients and also
for the surveillance of MRSA. The gold standard for con-
firmation of MRSA is regarded as the molecular detection
of either mecA, typically by PCR, or of PBP2a/PBP20,
usually by antibody detection with commercially available
slide agglutination assays. Crucial to the reliability of
these assays is the fact that mecA and PBP2a/PBP20 are
both highly conserved among MRSA isolates.
Discovery of mecC MRSA: genome sequencing to
identify a novel resistance gene
An epidemiological study of bovine mastitis [5] led to the
isolation in 2007 of a S. aureus isolate, LGA251, from a
bulk tank milk sample in southwest England which was
phenotypically MRSA (i.e., resistant to oxacillin and cefox-
itin). At that time this in itself was immediately significant
because it represented the first detection of MRSA in the
UK dairy herd. However, confirmatory tests for the mecA
S. aureus LGA251 SCCmec type XI
blaZ–ΔmecC1–mecR1–mecI
ABC transporter
cluster3′-end of ACME
aL
iolR
ABC
transporterlip
IR
orfX ΔcopA
A B C D G2 E iolG J K
myo-Inositol ulizaon cluster
S. xylosus S04009
aL
/
aR aL aL2
SCCmec type VII mecC region
ccrB ccrAmecA–mecR1–mecI arsCBRcadD cadA cadC
blaZ–mecC –mecR1 –mecI
S. sciuri GVGS2 SCCmec–mecC
hybrid
blaZ–mecC–mecR1–mecIaR arsCBR
Δlip ABCtransporter
4 kb
% G/C
TRENDS in Microbiology 
Figure 1. Comparison of the mecC1 region in Staphylococcus xylosus strain S04009 [38] (EMBL accession number HE993884), SCCmec type XI in Staphylococcus aureus
LGA251 [6] (EMBL FR821779), and a hybrid SCCmec–mecC in S. sciuri strain GVGS2 [39] (EMBL HG515014). Areas in red show regions conserved between the two
sequences; homologous coding sequences are marked in the same colour. Blue and red dots indicate the SCCmec attachment sites (attL and attR) and inverted repeats (IR),
respectively. The %G/C content of the region is shown above each genome schematic. Abbreviations: ABC, ATP-binding cassette; ACME, arginine catabolic mobile element;
SCCmec, staphylococcal cassette chromosome.
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sequencing of LGA251 at the Wellcome Trust Sanger
Institute revealed that the strain carried a novel mecA
homologue, initially termed mecALGA251, which was only
69% identical to conventional mecA at the DNA level, and
the encoded PBP2a/20 was 63% identical at the amino
acid level [6]. This explained the resistance of LGA251 and
why it produced negative results by mecA PCR and PBP2a/
20 slide agglutination. A retrospective search of isolate
collections in the UK and Denmark identified a further
65 isolates positive for mecALGA251 isolated not only from
dairy cattle but also from humans, including the earliest
known isolate, a Danish blood isolate from 1975 [6]. In
consequence, although mecALGA251 MRSA has only recent-
ly been recognised, it may have been causing human
infections for over 35 years. These mecALGA251 MRSA
isolates belonged predominantly to CC130 and ST425
[6]. Similarly to conventional mecA, mecALGA251 is located
within a SCCmec element inserted into the 30 region of orfX
(Figure 1). The LGA251 SCCmec was also novel; in other
words, it had divergent ccrA and ccrB recombinases (be-
longing to the ccrA1 and ccrB3 groups and representing a
novel combination of recombinase groups designated type
8 ccr), divergent mecA regulatory genes (mecI/mecR), and
the absence of one of the three joining regions (J3) that are
normally present [6]. The SCCmec sequence from LGA251
was submitted to the Working Group on the Classificationof SCC and given the designation type XI SCCmec in
November 2009. mecALGA251 was itself subsequently
renamed mecC in 2012 [7]. mecC was chosen because an
additional divergent homologue of mecA, distinct from
mecALGA251, had already been described in Macrococcus
caseolyticus [8] and was designated mecB [7]. Published at
the same time as the UK and Danish report [6], work in the
Republic of Ireland independently described mecC and
type XI SCCmec in human MRSA strains isolated in
2010 and belonging to CC130 [9].
Functional characterisation of mecC-encoded PBP2a
The function of the mecC-encoded PBP2a/20 and its role in
b-lactam resistance was formally demonstrated by the
work of Kim et al. which also highlighted noteworthy
differences in the properties of the mecA and mecC-encoded
proteins [10]. Although the detection of mecC-encoded
PBP2a in LGA251 was problematic, most likely due to
low expression levels resulting from mecI/mecR, inducible
expression of mecC in a methicillin-sensitive S. aureus
(MSSA) strain conferred high minimum inhibitory concen-
tration (MIC) values against a range of b-lactams [10].
Recombinant PBP2amecC protein was bound by b-lactams
but showed higher affinity for oxacillin compared to cefox-
itin, whereas PBP2amecA showed less preference. The two
proteins also displayed differences in their thermostabilty
and temperature optima, with PBP2amecC appearing to be43
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mecC did not require the presence of the native PBP2 to
confer high-level oxacillin resistance. This is in contrast to
PBP2amecA for which high-level oxacillin resistance
requires the presence of native PBP2 to provide transgly-
cosylase activity lacking in PBP2amecA. Because PBP2a-
mecC also appears to lack transglycosylase activity, high-
level oxacillin resistance conferred by mecC is likely to
involve collaboration between PBP2amecC and one of the
other monofunctional glycotransferases that are known to
be induced in S. aureus when PBP2 is inhibited [10].
Although this characterisation confirms the function of
mecC-encoded PBP2a as a transpeptidase, and its role
in methicillin resistance, there are important differences
in the behaviour of the proteins encoded by mecC and
mecA. The structural and evolutionary bases for these
distinctions are not yet clear.
The issue of mecC MRSA detection
Although there are obviously differences in biochemistry
between mecA and mecC-encoded PBP2a, mecC nonethe-
less confers methicillin resistance, and such strains need to
be identified correctly as MRSA in diagnostic laboratories.
Where laboratories are performing antimicrobial suscepti-
bility testing, mecC MRSA will likely be correctly identified
as MRSA. Importantly, cefoxitin has been found to be more
reliable than oxacillin in disc diffusion, broth microdilu-
tion, and agar dilution assays [11]. However, significant
differences in the reliability of agars from different man-
ufacturers have been described [11].
Similarly, mecC MRSA produce a distinctive antibiotic
susceptibility profile compared to mecA MRSA when
assayed using the automated Vitek 2 system from BioMe´r-
ieux [12]. Where both oxacillin and cefoxitin are included,
mecA MRSA, as might be expected, typically display resis-
tance to both. By contrast, the majority of mecC MRSA
show resistance to cefoxitin, and are therefore reported as
MRSA, but however show susceptibility to oxacillin. Test-
ing of a panel of 896 S. aureus isolates (comprising mecA
MRSA, mecC MRSA, and mec-negative MSSA) found that
this oxacillin-sensitive/cefoxitin-resistant profile had a
sensitivity of 88.7% and a specificity of 99.5% for the
identification of mecC MRSA isolates from MSSA and
mecA MRSA [12]. This profile therefore provides a zero-
cost screening method for identification of mecC-positive
MRSA strains in the many clinical laboratories already
using Vitek 2, although subsequent PCR would be needed
to confirm mecC status. The performance of other auto-
mated systems for the detection of mecC MRSA resistance
has not been fully tested and reported.
The differences in oxacillin and cefoxitin sensitivities
displayed by mecC MRSA isolates are consistent with the
findings of Kim et al. discussed above, demonstrating that
the mecC-encoded PBP2a, unlike the mecA-encoded coun-
terpart, has a higher relative affinity for oxacillin than for
cefoxitin, leading to higher levels of resistance to cefoxitin
than to oxacillin [10].
mecC MRSA appear to grow reliably on commercial
chromogenic agar plates designed to identify MRSA, al-
though there are indications that some MRSA agars may
perform better than others for the recovery of mecC MRSA44[13]. mecC MRSA typically have lower MICs to oxacillin
and cefoxitin than their mecA counterparts, and this may
affect their recovery on selective agars.
One major problem is where molecular detection of
mecA is used to identify or confirm MRSA. Laboratories
using this approach, most often PCR, will need to consider
incorporating universal mec gene primers able to amplify
both mecA and mecC or the addition of mecC-specific
primers. This latter option has the benefit of differentiat-
ing mecC MRSA, thereby facilitating their surveillance
and the isolation of strains for further characterisation.
Various modified PCR assays have been developed to
detect and/or differentiate mecC MRSA [14–16], and many
commercial PCR-based assays are being, or have been,
modified to include mecC detection [14,17]. Commercial
slide agglutination assays for mecA-encoded PBP2a will
also misidentify mecC MRSA as being methicillin-suscep-
tible. These tests may be modified in due course to detect
mecC MRSA, but currently the use of commercial slide
agglutination assays alone will produce false-negative
results for these strains. Strains found to be phenotypically
resistant but mecA and/or PBP2a-negative are potentially
mecC MRSA, and mecC PCR would be warranted to con-
firm this. mec gene-negative MRSA have also been
reported [18].
In summary, mecC MRSA pose a potential diagnostic
loophole which clinical microbiology laboratories should be
aware of and which will require validation of testing
approaches to ensure that mecC MRSA are correctly iden-
tified as MRSA. Statistically robust, formal studies are
needed to validate the diverse MRSA susceptibility testing
regimes for their correct identification of mecC MRSA as
methicillin-resistant, even if only to confirm that current
methods are sufficient.
Epidemiology of mecC MRSA in humans and animals
Following the original discoveries of mecC MRSA in the
UK, Denmark, and the Republic of Ireland such strains,
both human and animal origin, were rapidly identified in a
further 10 Western European countries (Table 1). In many
cases these reports represent small numbers of isolates
identified by opportunistic sampling; for example, retro-
spective testing of previously identified atypical MRSA
isolates. From these data it is unclear how common mecC
MRSA truly are. In Denmark, however, where reporting of
human MRSA is mandatory and extensive strain collec-
tions are maintained, the prevalence of mecC MRSA
among all MRSA was found to be 1.9% in 2010, increasing
to 2.8% in 2011 [19]. Further evidence supporting a recent
increase is that very few Danish S. aureus isolates collected
prior to 2003 were found to be mecC MRSA [19]. By
comparison, large-scale collection and characterisation of
human MRSA in Germany found only two mecC MRSA
isolates among 3207 MRSA isolates (prevalence 0.06%),
with no indication of a change in prevalence between 2004/
05 and 2010/11 [20]. In the UK, a study in England during
2011–2012 surveyed 335 sequential MRSA isolates from
individual patients collected from each of six clinical mi-
crobiological laboratories, and found a prevalence rate for
mecC MRSA of 0.45% (nine mecC MRSA isolates from a
total of 2010 MRSA isolates collected) [21]. The screening
Table 1. Distribution and characteristics of reported mecC MRSA
Country Host species Earliest
reported
isolate
spa-types Multilocus sequence types
(clonal complex)
Refs
UK Human, dairy cattle, wild
common seal, wild
chaffinch, domestic dog
1993 t6300, t6292, t6220, t843, t6293,
t1736, t1535, t7947, t7485, t7946,
t7945, t6383, t742, t7734, t978,
t6594, t7914, t9376, t6386, t9605,
t8833, t11702, t11706, t9280
ST425 (CC425), ST130 (CC130),
ST1245 (CC130), ST1526
(CC130), ST1944 (CC130),
ST1764 (CC130), 1943 (CC1943/
1946), ST1945 (CC130), ST1946
(CC1943/1946), ST2179 (CC599)
[6,15,21,
26,33]
Denmark Human, cattle, sheep 1975 t373, t528, t6220, t9397, t978,
t2345, t3391, t8835, t9395, t843,
t1535, t528, t1773, t1048, t3256,
t1532, t1736,
t3218, t3570, t5970, t9397, t5930
and t7603.
ST130 (CC130), ST1943 (CC130) [6,33,42,43]
Republic of Ireland Human 2010 t843 and t373 ST130 (CC130), ST1764 (CC130) [9]
Germany Human, wild hare, sheep,
domestic dog, domestic
cat, domestic guinea pig
2004 t843, t10513, t1736, 1773, t978,
t7189, t1535, t10033, t10006,
t1694, t278, t10009
ST130 (CC130), ST1945 (CC130),
ST599 (CC599), ST2361 (CC1943/
1946)
[13,20,37,
44,45]
France Human, dairy cattle 2007 t9280, t843 ST130 (CC130), ST1945 (CC130) [31,46]
The Netherlands Human Not provided Not provided Not provided [35]
Belgium Wild brown rat, farmed
rabbit, dairy cattle, beef
cattle
1995 t208, t742, t9925, t1736 ST2273 (CC49), ST425 (CC425),
ST2508 (CC599), ST130 (CC130)
[33,47]
Sweden Dairy cattle, wild
hedgehog
2003 t524, t9111 ST130 (CC130), ST425 (CC425) [36,48]
Norway Domestic cat 2012 t6902 ST2497 (CC1943/1946) [32]
Austria Wild European otter and
wild European hedgehog
Winter 2012/13 t4335 and t3256 ST2620 (CC130), ST130 (CC130) [37]
Spain Human 2008 t843 and t6220 ST130 (CC130), ST1945 (CC130) [30,49]
Switzerland Human 2011 t11150 ST130 (CC130) [22]
Finland Dairy cattle 2006 t3256 ST130 (CC130) [50]
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in western Switzerland did not identify any mecC MRSA
isolates, suggesting that these are also rare in that country
[22]. mecC MRSA has yet to be reported from outside
Western Europe, and a small survey of US service person-
nel injured during deployment in Iraq and Afghanistan
and transitioned through Germany en route to the USA
found no mecC MRSA among 102 MRSA isolates [23].
mecC MRSA currently appears to be uncommon in
humans, but there are interesting geographical differences
in prevalence; the recent increase in Denmark highlights
the need to monitor mecC MRSA.
Although a number of multilocus sequence types have
been found among mecC MRSA isolates, two major
lineages are responsible for the vast majority of isolates
to date: CC130, which seems to predominate, and ST425.
Among these lineages a large number of spa-types are
represented (Table 1), with t843, associated with CC130,
being the most common. mecC-negative ST425 have also
been reported [24], as have CC130 MSSA, although the
mec gene status of the latter was not confirmed [25].
mecC MRSA have been found in a wide range of other
host species encompassing livestock, wildlife, and compan-
ion animals from many European countries (Table 1). As
with human isolates, these isolates predominantly belong
to CC130 and to a lesser degree ST425. These lineages
therefore appear to have a very broad host tropism. There
are few data on the prevalence among animals, although a
British study of bovine bulk tank milk found that 2.67% of
dairy farms in England were positive for mecC MRSA but,interestingly, no positive farms were found in Scotland
during the same survey [26]. Assessing the prevalence of
mecC MRSA among different livestock species, under-
standing their role in veterinary disease, and the risk of
zoonotic transmission are important topics for future re-
search.
Zoonotic potential of mecC MRSA
Both CC130 [27] and ST425 [6] have previously been
regarded as animal-adapted lineages of S. aureus, suggest-
ing that mecC MRSA arose in animals, possibly ruminants,
and subsequently spread to humans [6]. Although the
origins of mecC MRSA are not yet clear there is good
evidence that contact with animals poses a zoonotic risk
and that mecC MRSA can be transmitted between species –
and therefore could be regarded as a LA-MRSA. For in-
stance, most isolates in Denmark come from rural areas
[19], and epidemiological follow-up of 22 patients found
known animal contact in four cases [19]. Genome sequenc-
ing of mecC MRSA isolates from two of these cases provid-
ed compelling evidence of cross-species transmission with
human and individual animal (cow and sheep) isolates
being separated by only a few single-nucleotide polymor-
phisms across the entire core genome [28]. A survey of
delegates at British Cattle Veterinary Association Con-
gress in 2011 failed to find any mecC MRSA, providing
evidence that the prevalence in this population is below 1%
[29]. However, many cases of mecC MRSA do not have
apparent animal contact, and household transmission be-
tween people has been demonstrated [30].45
Box 1. Outstanding questions
 How widespread and common are mecC MRSA strains? To date
they have only been reported in Western Europe, but are they
present elsewhere, remaining undetected, or will they spread
elsewhere?
 What are the cause(s) of the recent increase in prevalence
reported from Denmark; will this continue and will this be seen
elsewhere?
 How common are mecC MRSA strains among animal populations
(wild, companion, and livestock), and how important are they for
animal health or as a zoonotic reservoir for human MRSA
infections?
 How and where did mecC and SCCmec type XI originate, and
when and how often have they been acquired by Staphylococcus
aureus? Why is CC130, and to a lesser degree ST425, so dominant
among mecC MRSA isolates? Will it spread to other lineages, and
will current mecC MRSA lineages acquire additional resistance
determinants?
 What is the basis for the apparent broad host specificity shown by
the mecC MRSA lineages CC130 and ST425?
 What is the structural and evolutionary basis for the functional
differences between mecA and mecC-encoded PBP2a/20?
 What are the best methods (e.g., chromogenic plates or
antimicrobial susceptibility testing approaches) to detect mecC
MRSA? Do diagnostic work-flows need to be altered to improve
mecC MRSA detection?
 What is the distribution and prevalence of mecC among other
staphylococci, and do these contribute to disease in animals and
humans? Did they play a role in the origin of mecC and its
dissemination to S. aureus?
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mecC MRSA have been isolated from carriage and a range
of infections in humans (see Table 1 for list of references).
These are predominantly skin and soft-tissue infections
but include severe bone infections [31], nosocomial pneu-
monia [13] and fatal bacteraemia [30]. mecC MRSA can
also cause disease in veterinary species; for example,
mastitis in dairy cattle has been noted in several coun-
tries, and other examples include chronic conjunctivitis
in a domestic cat [32] and a rabbit isolate of mecC MRSA
from Belgium belonging to a highly virulent clone among
farmed rabbits [33,34]. It appears that, similarly to con-
ventional MRSA lineages, mecC MRSA strains are high-
ly-versatile pathogens able to cause a wide range of
infections in a range of host species, including severe
and fatal infections. In agreement with these epidemio-
logical observations, microarray analysis and genome
sequencing reveal that mecC MRSA isolates encode sev-
eral known or putative S. aureus virulence factors, in-
cluding several adhesins, superantigens, and toxins
[13,28,35]. In addition, a novel allele of etd (encoding
exfoliative toxin D) with only 59% identify to the previ-
ously described etd gene was identified in CC130 isolates,
and was putatively named etd2 [28,36]. However, where
tested, mecC MRSA strains have been negative for Pan-
ton–Valentine leukocidin [15,19], a prominent virulence
factor among CA-MRSA, and they have been negative for
the human immune evasion genes sak, chp, and scn
[13,35], consistent with a possible origin for these strains
in an animal reservoir.
Resistance to non-b-lactam antibiotics is currently un-
common among mecC MRSA isolates, and MICs for oxa-
cillin and cefoxitin are generally low compared to those
that can be seen among mecA MRSA. It will be of interest
and of potential importance to monitor if these features
change in the future.
mecC in other species of staphylococci
The origins of mecC MRSA and SCCmec type XI are
unclear, but mecC has also been detected by PCR in
Staphylococcus stepanovicii from a wild European lynx
in Austria [37], and a homologue, mecC1, located within
a SCCmec IX-like element has been described using
genome sequencing of Staphylococcus xylosus isolated
from bovine milk in France [38] (Figure 1). This latter
gene has 93.5% sequence identity to mecC in MRSA and
is therefore classed as an allotype of mecC (70% but
<95% nucleotide sequence identify) [7,38]. Finally, mecC
has been found in Staphylcoccus scirui within a novel
hybrid SCCmec–mecC element in isolates from caesare-
an incision wounds in Belgian Blue cattle [39] (Figure 1).
As suggested for mecA [40,41], it is possible that mecC
has its origin among coagulase-negative staphylococci;
further investigations, including whole-genome sequenc-
ing of mecC staphylococci, may offer clues to the origin
and evolution of this resistance determinant. These data
also mean that clinical microbiology laboratories should
be aware not only of mecC MRSA but also of the possible
occurrence of mecC in other pathogenic species of methi-
cillin-resistant staphylococci.46Concluding remarks
mecC MRSA represent a recently recognised form of
MRSA, encoding a divergent mec gene, which can colonise
and cause disease in humans and a wide range of other host
species. Although mecC MRSA are currently rare, and
have only been reported in Europe to date, they present
a potential diagnostic problem where there is reliance on
mecA or PBP2a/20 detection for MRSA diagnosis, and their
emergence raises a several questions for future research
(Box 1).
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